The FDA issues the first warning letters following its marketing denial orders. Read More
Tags :PMTA
The rules reflect clarifying changes but no significant substantive changes.Read More
Turning Point accuses the FDA of ‘moving the goalposts’ for a marketing application. Read More
The organizations cite concerns about youth appeal and public health impact.Read More
Companies find themselves torn between their obligations to the law and to the safety of users. Read More
The company says it will continue its dialogue with the agency.Read More
The FDA mischaracterized the Artic (Menthol) Bidi Stick as a flavored product, says firm. Read More
Tom Miller is concerned about unintended consequences of removing cigarette alternatives. Read More
The agency withholds details on products not marketed to protect commercial information.Read More
Health campaigners may return to court to force the removal of unauthorized products by FDA. Read More
